help button home button Am J Pathol JNCI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paavonen, T.
Right arrow Articles by Renkonen, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paavonen, T.
Right arrow Articles by Renkonen, R.

American Journal of Pathology, Vol 141, 1259-1264, Copyright © 1992 by American Society for Investigative Pathology


REGULAR ARTICLES

Selective expression of sialyl-Lewis x and Lewis a epitopes, putative ligands for L-selectin, on peripheral lymph-node high endothelial venules

T Paavonen and R Renkonen
Department of Pathology, University of Helsinki, Finland.

High endothelial venules (HEV) lined by the high endothelium are the sites where leukocytes enter into the lymph nodes from the blood. Lymphocyte homing into lymph nodes is organ-selective, i.e., different molecules are involved in the lymphocyte homing to peripheral nodes compared with mucosa associated lymphoid tissue. The traffic into peripheral nodes is regulated by the expression of L-selectin on leukocytes and its ligand on HEVs. The ligand for L-selectin is suggested to be a 50, 90, or 105 kd glycoprotein, which is sulfated, fucosylated, and sialylated. The two other members of the selectin family (E- and P-selectin) recognize sialyl-Lewis x and -Lewis a (sLex and sLea, respectively) carbohydrate motifs, and there is preliminary data suggesting that this would also be the case for L-selectin. We have initiated a study to identify the expression of these sialylated structures on endothelial surfaces. We present data that show that HEVs in peripheral nodes, but not in the mucosa-associated lymphoid tissue, express large quantities of sLex and sLea identified by MAbs in immunohistology. Endothelium in capillaries or larger vessels in non- lymphoid tissues do not react with anti-sLex or -Lea mAbs. Only 1-2% of the lymphocytes in the peripheral blood express sLex and so far only the skin-homing lymphocytes are known to be sLex positive in larger quantities. We show that in many occasions the B cells in the peripheral lymph-node germinal centers are also sLex-, but not sLea- positive, and provide evidence of the restricted pattern of sLex and sLea expression on peripheral lymph-node HEVs. We propose that they are at least parts of the ligand for L-selectin.


This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
S. K. Toppila-Salmi, J. P. Myller, T. V. M. Torkkeli, J. V. Muhonen, J. A. Renkonen, M. E. Rautiainen, and R. L. O. Renkonen
Endothelial L-Selectin Ligands in Sinus Mucosa during Chronic Maxillary Rhinosinusitis
Am. J. Respir. Crit. Care Med., June 15, 2005; 171(12): 1350 - 1357.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
L. Huopaniemi, M. Kolmer, J. Niittymaki, M. Pelto-Huikko, and R. Renkonen
Inflammation-induced transcriptional regulation of Golgi transporters required for the synthesis of sulfo sLex glycan epitopes
Glycobiology, December 1, 2004; 14(12): 1285 - 1294.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
X. Zhou, J. G. Krueger, M.-C. J. Kao, E. Lee, F. Du, A. Menter, W. H. Wong, and A. M. Bowcock
Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array
Physiol Genomics, March 18, 2003; 13(1): 69 - 78.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. Renkonen, O. Tynninen, P. Hayry, T. Paavonen, and R. Renkonen
Glycosylation Might Provide Endothelial Zip Codes for Organ-Specific Leukocyte Traffic into Inflammatory Sites
Am. J. Pathol., August 1, 2002; 161(2): 543 - 550.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
S. Toppila, T. Paavonen, A. Laitinen, L. A. Laitinen, and R. Renkonen
Endothelial Sulfated Sialyl Lewis x Glycans, Putative L-Selectin Ligands, Are Preferentially Expressed in Bronchial Asthma but Not in Other Chronic Inflammatory Lung Diseases
Am. J. Respir. Cell Mol. Biol., October 1, 2000; 23(4): 492 - 498.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
L. Tu, P. G. Murphy, X. Li, and T. F. Tedder
L-Selectin Ligands Expressed by Human Leukocytes Are HECA-452 Antibody-Defined Carbohydrate Epitopes Preferentially Displayed by P-Selectin Glycoprotein Ligand-1
J. Immunol., November 1, 1999; 163(9): 5070 - 5078.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. D. Rosen
Endothelial Ligands for L-Selectin : From Lymphocyte Recirculation to Allograft Rejection
Am. J. Pathol., October 1, 1999; 155(4): 1013 - 1020.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Toppila, T. Paavonen, M. S. Nieminen, P. Hayry, and R. Renkonen
Endothelial L-Selectin Ligands Are Likely to Recruit Lymphocytes into Rejecting Human Heart Transplants
Am. J. Pathol., October 1, 1999; 155(4): 1303 - 1310.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
L. Tu, M. D. Delahunty, H. Ding, F. W. Luscinskas, and T. F. Tedder
The Cutaneous Lymphocyte Antigen Is an Essential Component of the L-selectin Ligand Induced on Human Vascular Endothelial Cells
J. Exp. Med., January 18, 1999; 189(2): 241 - 252.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Mitsuoka, M. Sawada-Kasugai, K. Ando-Furui, M. Izawa, H. Nakanishi, S. Nakamura, H. Ishida, M. Kiso, and R. Kannagi
Identification of a Major Carbohydrate Capping Group of the L-selectin Ligand on High Endothelial Venules in Human Lymph Nodes as 6-Sulfo Sialyl Lewis X
J. Biol. Chem., May 1, 1998; 273(18): 11225 - 11233.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
R. A. Clark, R. C. Fuhlbrigge, and T. A. Springer
L-Selectin Ligands That Are O-glycoprotease Resistant and Distinct from MECA-79 Antigen are Sufficient for Tethering and Rolling of Lymphocytes on Human High Endothelial Venules
J. Cell Biol., February 9, 1998; 140(3): 721 - 731.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the American Society for Investigative Pathology.